# Quest Resource Holding Corp: financial statements, quarterly

QRHC · Nasdaq · CIK 1442236 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/qrhc.md) · [Financials](/companies/qrhc/financials.md) · [Filings](/companies/qrhc/filings.md) · [Insiders](/companies/qrhc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/qrhc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [70.4](/filings/0000950170-24-123237.md) | [69.3 d](/filings/0000950170-25-037891.md) | [72.7](/filings/0000950170-25-069129.md) | [73.1](/filings/0000950170-25-106524.md) | [72.8](/filings/0001193125-25-274169.md) | [70.0 d](/filings/0001193125-26-104675.md) | [68.4](/filings/0001193125-26-212552.md) | [59.5](/filings/0001193125-26-338544.md) | [63.3](/filings/0001193125-25-274169.md) | [58.9 d](/filings/0001193125-26-104675.md) | [61.7](/filings/0001193125-26-212552.md) | [64.1](/filings/0001193125-26-338544.md) |
| Cost of revenue | $m | [58.0](/filings/0000950170-24-123237.md) | [57.8 d](/filings/0000950170-25-037891.md) | [58.6](/filings/0000950170-25-069129.md) | [59.6](/filings/0000950170-25-106524.md) | [61.1](/filings/0001193125-25-274169.md) | [59.2 d](/filings/0001193125-26-104675.md) | [57.5](/filings/0001193125-26-212552.md) | [48.5](/filings/0001193125-26-338544.md) | [51.9](/filings/0001193125-25-274169.md) | [49.8 d](/filings/0001193125-26-104675.md) | [52.1](/filings/0001193125-26-212552.md) | [53.6](/filings/0001193125-26-338544.md) |
| Gross profit | $m | [12.4](/filings/0000950170-24-123237.md) | [11.5 d](/filings/0000950170-25-037891.md) | [14.0](/filings/0000950170-25-069129.md) | [13.5](/filings/0000950170-25-106524.md) | [11.7](/filings/0001193125-25-274169.md) | [10.7 d](/filings/0001193125-26-104675.md) | [10.9](/filings/0001193125-26-212552.md) | [11.0](/filings/0001193125-26-338544.md) | [11.5](/filings/0001193125-25-274169.md) | [9.1 d](/filings/0001193125-26-104675.md) | [9.7](/filings/0001193125-26-212552.md) | [10.4](/filings/0001193125-26-338544.md) |
| Selling, general and administrative | $m | [9.6](/filings/0000950170-24-123237.md) | [9.4 d](/filings/0000950170-25-037891.md) | [9.8](/filings/0000950170-25-069129.md) | [9.4](/filings/0000950170-25-106524.md) | [10.3](/filings/0001193125-25-274169.md) | [10.1 d](/filings/0001193125-26-104675.md) | [11.4](/filings/0001193125-26-212552.md) | [9.3](/filings/0001193125-26-338544.md) | [9.2](/filings/0001193125-25-274169.md) | [7.7 d](/filings/0001193125-26-104675.md) | [8.4](/filings/0001193125-26-212552.md) | [8.2](/filings/0001193125-26-338544.md) |
| Operating income | $m | [0.5](/filings/0000950170-24-123237.md) | [(0.3) d](/filings/0000950170-25-037891.md) | [1.9](/filings/0000950170-25-069129.md) | [1.8](/filings/0000950170-25-106524.md) | [(0.9)](/filings/0001193125-25-274169.md) | [(7.2) d](/filings/0001193125-26-104675.md) | [(8.2)](/filings/0001193125-26-212552.md) | [0.4](/filings/0001193125-26-338544.md) | [1.1](/filings/0001193125-25-274169.md) | [0.5 d](/filings/0001193125-26-104675.md) | [0.2](/filings/0001193125-26-212552.md) | [(10.0)](/filings/0001193125-26-338544.md) |
| Interest expense | $m | [2.4](/filings/0000950170-24-123237.md) | [2.3 d](/filings/0000950170-25-037891.md) | [2.5](/filings/0000950170-25-069129.md) | [2.6](/filings/0000950170-25-106524.md) | [2.7](/filings/0001193125-25-274169.md) | [2.5 d](/filings/0001193125-26-104675.md) | [2.3](/filings/0001193125-26-212552.md) | [2.4](/filings/0001193125-26-338544.md) | [2.4](/filings/0001193125-25-274169.md) | [2.2 d](/filings/0001193125-26-104675.md) | [2.1](/filings/0001193125-26-212552.md) | [2.2](/filings/0001193125-26-338544.md) |
| Income tax | $m | [0.1](/filings/0000950170-24-123237.md) | [(0.3) d](/filings/0000950170-25-037891.md) | [0.1](/filings/0000950170-25-069129.md) | [0.7](/filings/0000950170-25-106524.md) | [(0.3)](/filings/0001193125-25-274169.md) | [(0.2) d](/filings/0001193125-26-104675.md) | [(0.0)](/filings/0001193125-26-212552.md) | [(0.0)](/filings/0001193125-26-338544.md) | [0.0](/filings/0001193125-25-274169.md) | [0.0 d](/filings/0001193125-26-104675.md) | [0.0](/filings/0001193125-26-212552.md) | [0.0](/filings/0001193125-26-338544.md) |
| Net income | $m | [(2.1)](/filings/0000950170-24-123237.md) | [(2.3) d](/filings/0000950170-25-037891.md) | [(0.7)](/filings/0001193125-25-274169.md) | [(1.5)](/filings/0001193125-25-274169.md) | [(3.4)](/filings/0001193125-25-274169.md) | [(9.5) d](/filings/0001193125-26-104675.md) | [(10.4)](/filings/0001193125-26-338544.md) | [(2.0)](/filings/0001193125-26-338544.md) | [(1.3)](/filings/0001193125-25-274169.md) | [(1.7) d](/filings/0001193125-26-104675.md) | [(2.3)](/filings/0001193125-26-338544.md) | [(12.2)](/filings/0001193125-26-338544.md) |
| Diluted EPS | $ per share | [(0.10)](/filings/0000950170-24-123237.md) | not reported | [(0.03)](/filings/0000950170-25-069129.md) | [(0.07)](/filings/0000950170-25-106524.md) | [(0.16)](/filings/0001193125-25-274169.md) | not reported | [(0.50)](/filings/0001193125-26-212552.md) | [(0.09)](/filings/0001193125-26-338544.md) | [(0.06)](/filings/0001193125-25-274169.md) | not reported | [(0.11)](/filings/0001193125-26-212552.md) | [(0.57)](/filings/0001193125-26-338544.md) |
| Basic EPS | $ per share | [(0.10)](/filings/0000950170-24-123237.md) | not reported | [(0.03)](/filings/0000950170-25-069129.md) | [(0.07)](/filings/0000950170-25-106524.md) | [(0.16)](/filings/0001193125-25-274169.md) | not reported | [(0.50)](/filings/0001193125-26-212552.md) | [(0.09)](/filings/0001193125-26-338544.md) | [(0.06)](/filings/0001193125-25-274169.md) | not reported | [(0.11)](/filings/0001193125-26-212552.md) | [(0.57)](/filings/0001193125-26-338544.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.9](/filings/0000950170-23-063666.md) | [0.3](/filings/0000950170-25-037891.md) | [0.6](/filings/0000950170-24-056831.md) | [1.0](/filings/0000950170-24-093847.md) | [1.1](/filings/0000950170-24-123237.md) | [0.4](/filings/0001193125-26-104675.md) | [1.4](/filings/0000950170-25-069129.md) | [0.4](/filings/0000950170-25-106524.md) | [1.1](/filings/0001193125-25-274169.md) | [1.0](/filings/0001193125-26-338544.md) | [1.1](/filings/0001193125-26-212552.md) | [1.0](/filings/0001193125-26-338544.md) |
| Current assets | $m | [53.5](/filings/0000950170-23-063666.md) | [60.6](/filings/0000950170-25-037891.md) | [62.9](/filings/0000950170-24-056831.md) | [66.0](/filings/0000950170-24-093847.md) | [64.6](/filings/0000950170-24-123237.md) | [75.1](/filings/0001193125-26-104675.md) | [68.0](/filings/0000950170-25-069129.md) | [56.7](/filings/0000950170-25-106524.md) | [54.0](/filings/0001193125-25-274169.md) | [51.2](/filings/0001193125-26-338544.md) | [54.5](/filings/0001193125-26-212552.md) | [52.3](/filings/0001193125-26-338544.md) |
| Total assets | $m | [170](/filings/0000950170-23-063666.md) | [177](/filings/0000950170-25-037891.md) | [179](/filings/0000950170-24-056831.md) | [182](/filings/0000950170-24-093847.md) | [178](/filings/0000950170-24-123237.md) | [176](/filings/0001193125-26-104675.md) | [166](/filings/0000950170-25-069129.md) | [153](/filings/0000950170-25-106524.md) | [149](/filings/0001193125-25-274169.md) | [146](/filings/0001193125-26-338544.md) | [148](/filings/0001193125-26-212552.md) | [134](/filings/0001193125-26-338544.md) |
| Current liabilities | $m | [44.6](/filings/0000950170-23-063666.md) | [44.9](/filings/0000950170-25-037891.md) | [43.0](/filings/0000950170-24-056831.md) | [44.4](/filings/0000950170-24-093847.md) | [42.5](/filings/0000950170-24-123237.md) | [44.4](/filings/0001193125-26-104675.md) | [46.5](/filings/0000950170-25-069129.md) | [39.8](/filings/0000950170-25-106524.md) | [40.8](/filings/0001193125-25-274169.md) | [39.5](/filings/0001193125-26-338544.md) | [42.5](/filings/0001193125-26-212552.md) | [44.4](/filings/0001193125-26-338544.md) |
| Total liabilities | $m | [103](/filings/0000950170-23-063666.md) | [111](/filings/0000950170-25-037891.md) | [113](/filings/0000950170-24-056831.md) | [116](/filings/0000950170-24-093847.md) | [115](/filings/0000950170-24-123237.md) | [121](/filings/0001193125-26-104675.md) | [121](/filings/0000950170-25-069129.md) | [110](/filings/0000950170-25-106524.md) | [107](/filings/0001193125-25-274169.md) | [105](/filings/0001193125-26-338544.md) | [109](/filings/0001193125-26-212552.md) | [107](/filings/0001193125-26-338544.md) |
| Long-term debt | $m | [56.8](/filings/0000950170-23-063666.md) | [64.6](/filings/0000950170-25-037891.md) | [68.5](/filings/0000950170-24-056831.md) | [70.7](/filings/0000950170-24-093847.md) | [71.9](/filings/0000950170-24-123237.md) | [76.3](/filings/0001193125-26-104675.md) | [74.1](/filings/0000950170-25-069129.md) | [69.7](/filings/0000950170-25-106524.md) | [65.4](/filings/0001193125-25-274169.md) | [64.0](/filings/0001193125-26-338544.md) | [63.4](/filings/0001193125-26-212552.md) | [59.4](/filings/0001193125-26-338544.md) |
| Current portion of debt | $m | [1.2](/filings/0000950170-23-063666.md) | [1.2](/filings/0000950170-25-037891.md) | [1.2](/filings/0000950170-24-056831.md) | [1.2](/filings/0000950170-24-093847.md) | [1.2](/filings/0000950170-24-123237.md) | [1.7](/filings/0001193125-26-104675.md) | [1.5](/filings/0000950170-25-069129.md) | [1.5](/filings/0000950170-25-106524.md) | [1.4](/filings/0001193125-25-274169.md) | [1.0](/filings/0001193125-26-338544.md) | [0.5](/filings/0001193125-26-212552.md) | [0.5](/filings/0001193125-26-338544.md) |
| Shareholders' equity | $m | [67.7](/filings/0000950170-24-123237.md) | [66.3](/filings/0001193125-26-104675.md) | [66.3](/filings/0001193125-25-274169.md) | [65.6](/filings/0001193125-25-274169.md) | [62.8](/filings/0001193125-25-274169.md) | [54.2](/filings/0001193125-26-338544.md) | [44.4](/filings/0001193125-26-338544.md) | [42.9](/filings/0001193125-26-338544.md) | [42.0](/filings/0001193125-25-274169.md) | [40.5](/filings/0001193125-26-338544.md) | [38.7](/filings/0001193125-26-338544.md) | [26.8](/filings/0001193125-26-338544.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [350 d](/filings/0000950170-24-123237.md) | [(8,030) d](/filings/0000950170-25-037891.md) | [(1,652)](/filings/0000950170-25-069129.md) | [808 d](/filings/0000950170-25-106524.md) | [(475) d](/filings/0001193125-25-274169.md) | [(4,766) d](/filings/0001193125-26-104675.md) | [(1,058)](/filings/0001193125-26-212552.md) | [3,903 d](/filings/0001193125-26-338544.md) | [5,661 d](/filings/0001193125-25-274169.md) | [1,051 d](/filings/0001193125-26-104675.md) | [190](/filings/0001193125-26-212552.md) | [4,461 d](/filings/0001193125-26-338544.md) |
| Capital expenditure | $k | [39.6 d](/filings/0000950170-24-123237.md) | [54.1 d](/filings/0000950170-25-037891.md) | [1,923](/filings/0000950170-25-069129.md) | [2,236 d](/filings/0000950170-25-106524.md) | [108 d](/filings/0001193125-25-274169.md) | [416 d](/filings/0001193125-26-104675.md) | [168](/filings/0001193125-26-212552.md) | [9.0 d](/filings/0001193125-26-338544.md) | [29.0 d](/filings/0001193125-25-274169.md) | [45.0 d](/filings/0001193125-26-104675.md) | [80.0](/filings/0001193125-26-212552.md) | [3.0 d](/filings/0001193125-26-338544.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [19.4](/filings/0000950170-23-063666.md) | [19.9](/filings/0000950170-24-056831.md) | [20.0](/filings/0000950170-24-093847.md) | [20.1](/filings/0000950170-24-123237.md) | [20.4](/filings/0000950170-25-069129.md) | [20.5](/filings/0000950170-25-106524.md) | [20.7](/filings/0001193125-25-274169.md) | [20.9](/filings/0001193125-26-212552.md) | [20.9](/filings/0001193125-26-338544.md) | [21.0](/filings/0001193125-25-274169.md) | [21.2](/filings/0001193125-26-212552.md) | [21.3](/filings/0001193125-26-338544.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 21,092,856 at 2026-08-03, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-338544.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.